Fumio Suzuki

5-HT3 receptor antagonists. 1. New quinoline derivatives

Hiroaki Hayashi, Yoshikazu Miwa, Ichiro Miki et al. · Journal of Medicinal Chemistry · 1992 · 48 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Carbon-11-labeled KF21213: a highly selective ligand for mapping CNS adenosine A2A receptors with positron emission tomography

Wei-Fang Wang, Kiichi Ishiwata, Hiromi Nonaka et al. · Nuclear Medicine and Biology · 2000 · 42 citations

Medicine, Biomedical Sciences, Pharmacology +15

Endogenously released DOPA is a causal factor for glutamate release and resultant delayed neuronal cell death by transient ischemia in rat striata

Nobuya Furukawa, Nobutaka Arai, Yoshio Goshima et al. · Journal of Neurochemistry · 2001 · 38 citations

Life Sciences, Neurobiology, Neuroscience +17

L-DOPA Cyclohexyl Ester Is a Novel Stable and Potent Competitive Antagonist Against L-DOPA, as Compared to L-DOPA Methyl Ester

Yoshimi Misu, Yoshio Goshima, Takeaki Miyamae et al. · The Japanese Journal of Pharmacology · 1997 · 27 citations · Full text

Medicine, Neuroscience, Pharmacology +14

DOPA cyclohexyl ester, a competitive DOPA antagonist, protects glutamate release and resultant delayed neuron death by transient ischemia in hippocampus CA1 of conscious rats

Nobutaka Arai, Nobuya Furukawa, Takeaki Miyamae et al. · Neuroscience Letters · 2001 · 21 citations

Life Sciences, Neuroscience, Pharmacology +17